ARTICLE | Distillery Therapeutics
Therapeutics: Fatty acid synthase (FASN; FAS); epidermal growth factor receptor 2 (HER2; EGFR2; ErbB2; neu)
June 30, 2016 7:00 AM UTC
Cell culture and mouse studies identified an inhibitor of FASN activity that could help treat HER2-positive breast cancer. Chemical library screening and testing in a human liver cancer cell line iden...